Highlights and Quick Summary
- Net Current Asset Value for the quarter ending March 31, 2022 was $31.7 Million (a -22.75% decrease compared to previous quarter)
- Year-over-year quarterly Net Current Asset Value decreased by -35.78%
- Annual Net Current Asset Value for 2021 was $41 Million (a -24194.77% decrease from previous year)
- Annual Net Current Asset Value for 2020 was $-170 Thousand (a -98.97% decrease from previous year)
- Annual Net Current Asset Value for 2019 was $-16.5 Million (a 71.33% increase from previous year)
Visit stockrow.com/NVCN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Current Asset Value of Neovasc Inc.
Most recent Net Current Asset Valueof NVCN including historical data for past 10 years.Interactive Chart of Net Current Asset Value of Neovasc Inc.
Neovasc Inc. Net Current Asset Value for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $31.67 | – | – | – | – |
| 2021 | $41.0 | $45.53 | $49.32 | $55.1 | $41.0 |
| 2020 | $-0.17 | $-1.47 | $-8.91 | $-9.2 | $-0.17 |
| 2019 | $-16.54 | $-11.39 | $-6.17 | $-5.13 | $-16.49 |
| 2018 | $-9.59 | $-16.1 | $-5.53 | $-33.95 | $-9.63 |
| 2017 | $-38.64 | $-35.23 | $-29.78 | $-24.22 | $-38.73 |
| 2016 | – | $-17.5 | $-35.51 | $46.88 | $-17.5 |
| 2015 | $54.27 | $64.19 | $75.73 | $81.57 | $54.27 |
| 2014 | $15.37 | $21.21 | $23.29 | $25.28 | $15.37 |
| 2013 | $3.29 | $4.95 | $5.75 | $4.92 | $3.29 |
| 2012 | $5.98 | $1.87 | $2.43 | $3.48 | $5.98 |
| 2011 | $4.05 | – | – | – | $4.05 |
Business Profile of Neovasc Inc.
Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.